Contraceptives Market by Product [Drugs (oral, injectable and topical) Devices (condoms, IUDs, diaphragms, sponges, patches, implants, vaginal rings)], by Age Group (Age 15-24, Age 25-34, Age 35-44 and Above 44), by Education (Less Than High School, High School Graduate, College Graduate and Other College Degrees) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022
Contraception is the deliberate use of artificial methods to prevent pregnancy by interfering with the normal process of fertilization, ovulation, and implantation. The most common form of contraception, popularly known as fertility control or birth control, is a barrier method. It is available in two major forms in the market, namely, contraceptive drugs and devices. Contraceptive drugs include oral (pills), topical, and injectable contraceptives. Whereas, contraceptive devices include condom, Intrauterine devices (IUD), vaginal ring, implant, patch, diaphragms, sponges, and others. The major form of artificial contraception is the barrier method, especially condoms.
The world contraceptives market is expected to garner $43,812 million by 2022 from $28,175 million in 2015, registering a CAGR of 6.4% from 2016 to 2022. Increase in focus to prevent unwanted pregnancies, the incidence of STIs, and technological advancements in contraceptive methods majorly drive the market. Other birth control factors, such as family planning to improve the quality of life for both women and children and growth in adoption of modern contraceptives to control population have contributed majorly to the market growth. However, health risks associated with contraceptives, lack of social acceptance, and rise in prevalence of infertility among women hamper the Contraceptive market growth.
The world contraceptives market is segmented based on product, age group, education, end user, and geography. Based on product, the market is further segmented into contraceptive drugs and devices. Contraceptive drugs are further categorized into oral pills, topical, and injectable contraceptives. Among these, oral pills dominate the overall contraceptive drugs market, owing to their high success rate and increase in use as emergency contraceptive pills, also known as “morning pill”. In addition, contraceptive devices are further categorized into condom, IUD, vaginal ring, implant, patch, sponges, diaphragms, and others. Male condoms dominate the overall contraceptive device market due to the associated advantages such as cost-effective, fewer side effects, and ease of use.
Contraceptive market is further categorized by various age groups-15-24, 25-34, 35-44 and above 44 years, depending upon the usage and revenue generated by these age groups. On the basis of education the contraceptive market is further categorized into less than high school, high school graduate, college graduate, and other college degrees. Based on end user, the contraceptive market is segmented into household, hospitals, and, clinics. The world contraceptive market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA. These regions are further categorized into their respective countries. In 2015, North America accounted for the largest share in the contraceptive market due to factors, such as product innovations, large number of public awareness programs, and growth in incidence of unwanted pregnancies among teenagers. U.S. majorly contributes for the remarkable growth in North America especially due to the large consumer base for advanced contraception. In addition, the Asia-Pacific region is expected to offer lucrative opportunities to market players, due to increase in focus of key players to expand in the emerging economies, improvement of healthcare infrastructure, and growth in population in populace countries such as China and India.
Market players have adopted product launch and acquisition as their key strategies to sustain the intense competition in the contraceptives market. For instance, in May 2016, Allergan launched levonorgestrel-releasing intrauterine system (LILETTA) 52 mg, a hormone-releasing system placed in woman's uterus to prevent pregnancy for up to 3 years with effectiveness of more than 99%. Moreover, Actavis plc acquired Allergan, Inc. (U.S.), a pharmaceutical company to expand its product portfolio of women’s health and provide a robust platform for future product development.
KEY MARKET BENEFITS
The world contraceptives market is segmented into product, age group, education, end user, and geography.
By Product
The world contraceptives market is expected to garner $43,812 million by 2022 from $28,175 million in 2015, registering a CAGR of 6.4% from 2016 to 2022. Increase in focus to prevent unwanted pregnancies, the incidence of STIs, and technological advancements in contraceptive methods majorly drive the market. Other birth control factors, such as family planning to improve the quality of life for both women and children and growth in adoption of modern contraceptives to control population have contributed majorly to the market growth. However, health risks associated with contraceptives, lack of social acceptance, and rise in prevalence of infertility among women hamper the Contraceptive market growth.
The world contraceptives market is segmented based on product, age group, education, end user, and geography. Based on product, the market is further segmented into contraceptive drugs and devices. Contraceptive drugs are further categorized into oral pills, topical, and injectable contraceptives. Among these, oral pills dominate the overall contraceptive drugs market, owing to their high success rate and increase in use as emergency contraceptive pills, also known as “morning pill”. In addition, contraceptive devices are further categorized into condom, IUD, vaginal ring, implant, patch, sponges, diaphragms, and others. Male condoms dominate the overall contraceptive device market due to the associated advantages such as cost-effective, fewer side effects, and ease of use.
Contraceptive market is further categorized by various age groups-15-24, 25-34, 35-44 and above 44 years, depending upon the usage and revenue generated by these age groups. On the basis of education the contraceptive market is further categorized into less than high school, high school graduate, college graduate, and other college degrees. Based on end user, the contraceptive market is segmented into household, hospitals, and, clinics. The world contraceptive market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA. These regions are further categorized into their respective countries. In 2015, North America accounted for the largest share in the contraceptive market due to factors, such as product innovations, large number of public awareness programs, and growth in incidence of unwanted pregnancies among teenagers. U.S. majorly contributes for the remarkable growth in North America especially due to the large consumer base for advanced contraception. In addition, the Asia-Pacific region is expected to offer lucrative opportunities to market players, due to increase in focus of key players to expand in the emerging economies, improvement of healthcare infrastructure, and growth in population in populace countries such as China and India.
Market players have adopted product launch and acquisition as their key strategies to sustain the intense competition in the contraceptives market. For instance, in May 2016, Allergan launched levonorgestrel-releasing intrauterine system (LILETTA) 52 mg, a hormone-releasing system placed in woman's uterus to prevent pregnancy for up to 3 years with effectiveness of more than 99%. Moreover, Actavis plc acquired Allergan, Inc. (U.S.), a pharmaceutical company to expand its product portfolio of women’s health and provide a robust platform for future product development.
KEY MARKET BENEFITS
- This report provides the quantitative analysis of the current market and estimations for the period of 2014-2022 to identify the prevailing market opportunities.
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the world contraceptives market.
- The market is analyzed based on various regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided in the report.
- In-depth analyses of current research and developments within contraceptives market are provided along with key market dynamic factors to understand the market dynamics.
- Key market players in the market are profiled in this report along with detailed analysis of their strategies.
The world contraceptives market is segmented into product, age group, education, end user, and geography.
By Product
- Drugs
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Devices
- Condoms
- Female Condoms
- Male Condoms
- Intrauterine devices (IUDs)
- Hormonal IUDs
- Copper IUDs
- Diaphragms
- Sponges
- Patches
- Implants
- Vaginal Rings
- Others
- 15-24 years
- 25-34 years
- 35-44 years
- Above 44 years
- Less than high school
- High school graduate
- College graduate
- Other college degrees
- Household
- Hospitals
- Clinics
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Others
- Asia-Pacific
- Japan
- China
- Australia
- India
- Others
- LAMEA
- Japan
- China
- Australia
- India
- Others
- The Female Health Company
- Teva Pharmaceutical Industries Limited
- Allergan plc
- Bayer AG
- Pfizer, Inc.
- The Cooper Companies Inc.
- Ansell LTD.
- Mayer Laboratories
- Merck & Co., Inc.
- Church & Dwight, Co., Inc.
- Reckitt Benckiser Plc
- Warner Chilcott Company
- BioSante Pharmaceuticals Inc.
- Agile Therapeutics Inc.
- HLL Lifecare Limited
- MANKIND Pharmaceuticals
- TTK HealthCare
- Boehringer Ingelheim GmbH
- Watson Pharmaceuticals, Inc.
- V-Care Pharma Pvt. Ltd.
- Vardhman Life care pvt. Ltd.
- Cipla Limited.
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 High intensity of rivalry
3.4 Regulatory scenario
3.4.1 Government regulations across countries
3.4.2 Womens preventive services guideline
3.4.3 FDA-approved contraceptives method
3.4.4 The Affordable care act contraceptive coverage and advantages
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Rise in need to reduce unwanted pregnancy
3.5.1.2 Increasing awareness for contraceptives worldwide
3.5.1.3 Rising usage of oral contraceptives as preferred method to avoid unplanned pregnancy
3.5.1.4 Technological advancements in contraceptive methods
3.5.1.5 Upsurge in government and NGO initiatives promoting contraceptives
3.5.1.6 Increasing awareness about STDs
3.5.2 Restraints
3.5.2.1 Health risks associated with the use of contraceptive methods
3.5.2.2 Lack of social acceptance
3.5.3 Opportunities
3.5.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economies
CHAPTER 4 WORLD CONTRACEPTIVES MARKET, BY PRODUCT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Drugs
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Oral contraceptive or pills
4.2.4.1 Market size and forecast
4.2.5 Injectable contraceptives
4.2.5.1 Market size and forecast
4.2.6 Topical contraceptives
4.2.6.1 Market size and forecast
4.3 Contraceptive devices
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Condoms
4.3.4.1 Market size and forecast
4.3.4.2 Female condoms
4.3.4.2.1 MARKET SIZE AND FORECAST
4.3.4.3 Male condoms
4.3.4.3.1 MARKET SIZE AND FORECAST
4.3.5 Intrauterine devices (IUD)
4.3.5.1 Market size and forecast
4.3.5.2 Hormonal IUDs
4.3.5.2.1 MARKET SIZE AND FORECAST
4.3.5.3 Copper IUDs
4.3.5.3.1 MARKET SIZE AND FORECAST
4.3.6 Contraceptive diaphragms
4.3.6.1 Market size and forecast
4.3.7 Contraceptive sponges
4.3.7.1 Market size and forecast
4.3.8 Contraceptive patches
4.3.8.1 Market size and forecast
4.3.9 Sub-dermal contraceptive implants
4.3.9.1 Market size and forecast
4.3.10 Contraceptive vaginal rings
4.3.10.1 Market size and forecast
4.3.11 Others
4.3.11.1 Market size and forecast
CHAPTER 5 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP
5.1 Overview
5.1.1 Market size and forecast
5.2 15-24 years
5.2.1 Market size and forecast
5.3 25-34 years
5.3.1 Market size and forecast
5.4 35-44 years
5.4.1 Market size and forecast
5.5 Above 44 years
5.5.1 Market size and forecast
CHAPTER 6 WORLD CONTRACEPTIVES MARKET, BY EDUCATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Less than high school
6.2.1 Market size and forecast
6.3 High school graduate
6.3.1 Market size and forecast
6.4 College graduate
6.4.1 Market size and forecast
6.5 Other college degrees
6.5.1 Market size and forecast
CHAPTER 7 WORLD CONTRACEPTIVES MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Household
7.2.1 Market size and forecast
7.3 Hospitals
7.3.1 Market size and forecast
7.4 Clinics
7.4.1 Market size and forecast
CHAPTER 8 CONTRACEPTIVES MARKET, BY GEOGRAPHY, 2014-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.3.1 U.S. contraceptives market
8.2.3.2 Canada contraceptives market
8.2.3.3 Mexico contraceptives market
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.3.1 Germany contraceptives market
8.3.3.2 France contraceptives market
8.3.3.3 U.K. contraceptives market
8.3.3.4 Rest of Europe contraceptives market
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.3.1 Japan contraceptives market
8.4.3.2 China contraceptives market
8.4.3.3 Australia contraceptives market
8.4.3.4 India contraceptives market
8.4.3.5 Rest of Asia Pacific contraceptives market
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.3.1 Brazil contraceptives market
8.5.3.2 Turkey contraceptives market
8.5.3.3 Venezuela contraceptives market
8.5.3.4 South Africa contraceptives market
8.5.3.5 Rest of LAMEA contraceptives market
CHAPTER 9 COMPANY PROFILES
9.1 Mylan N.V.
9.1.1 Company overview
9.1.2 Operating business segments
9.1.3 Business performance
9.1.4 Key strategic moves & developments
9.2 Ansell Limited
9.2.1 Company overview
9.2.2 Operating business segments
9.2.3 Business performance
9.2.4 Key strategic moves & developments
9.3 Bayer AG
9.3.1 Company overview
9.3.2 Operating business segments
9.3.3 Business performance
9.3.4 Key strategic moves & developments
9.4 Church & Dwight Co., Inc.
9.4.1 Company overview
9.4.2 Operating business segments
9.4.3 Business performance
9.5 Merck & Co., Inc.
9.5.1 Company overview
9.5.2 Operating business segments
9.5.3 Business performance
9.6 Pfizer Inc.
9.6.1 Company overview
9.6.2 Operating business segments
9.6.3 Business performance
9.6.4 Key strategic moves & developments
9.7 Teva Pharmaceutical Industries Limited
9.7.1 Company overview
9.7.2 Operating business segments
9.7.3 Business performance
9.7.4 Key strategic moves & developments
9.8 The Cooper Companies, Inc.
9.8.1 Company overview
9.8.2 Operating business segments
9.8.3 Business performance
9.8.4 Key strategic moves & developments
9.9 The Female Health Company
9.9.1 Company overview
9.9.2 Operating business segments
9.9.3 Business performance
9.9.4 Key strategic moves & developments
9.10 Mayer Laboratories, Inc.
9.10.1 Company overview
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 High intensity of rivalry
3.4 Regulatory scenario
3.4.1 Government regulations across countries
3.4.2 Womens preventive services guideline
3.4.3 FDA-approved contraceptives method
3.4.4 The Affordable care act contraceptive coverage and advantages
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Rise in need to reduce unwanted pregnancy
3.5.1.2 Increasing awareness for contraceptives worldwide
3.5.1.3 Rising usage of oral contraceptives as preferred method to avoid unplanned pregnancy
3.5.1.4 Technological advancements in contraceptive methods
3.5.1.5 Upsurge in government and NGO initiatives promoting contraceptives
3.5.1.6 Increasing awareness about STDs
3.5.2 Restraints
3.5.2.1 Health risks associated with the use of contraceptive methods
3.5.2.2 Lack of social acceptance
3.5.3 Opportunities
3.5.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economies
CHAPTER 4 WORLD CONTRACEPTIVES MARKET, BY PRODUCT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Drugs
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Oral contraceptive or pills
4.2.4.1 Market size and forecast
4.2.5 Injectable contraceptives
4.2.5.1 Market size and forecast
4.2.6 Topical contraceptives
4.2.6.1 Market size and forecast
4.3 Contraceptive devices
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Condoms
4.3.4.1 Market size and forecast
4.3.4.2 Female condoms
4.3.4.2.1 MARKET SIZE AND FORECAST
4.3.4.3 Male condoms
4.3.4.3.1 MARKET SIZE AND FORECAST
4.3.5 Intrauterine devices (IUD)
4.3.5.1 Market size and forecast
4.3.5.2 Hormonal IUDs
4.3.5.2.1 MARKET SIZE AND FORECAST
4.3.5.3 Copper IUDs
4.3.5.3.1 MARKET SIZE AND FORECAST
4.3.6 Contraceptive diaphragms
4.3.6.1 Market size and forecast
4.3.7 Contraceptive sponges
4.3.7.1 Market size and forecast
4.3.8 Contraceptive patches
4.3.8.1 Market size and forecast
4.3.9 Sub-dermal contraceptive implants
4.3.9.1 Market size and forecast
4.3.10 Contraceptive vaginal rings
4.3.10.1 Market size and forecast
4.3.11 Others
4.3.11.1 Market size and forecast
CHAPTER 5 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP
5.1 Overview
5.1.1 Market size and forecast
5.2 15-24 years
5.2.1 Market size and forecast
5.3 25-34 years
5.3.1 Market size and forecast
5.4 35-44 years
5.4.1 Market size and forecast
5.5 Above 44 years
5.5.1 Market size and forecast
CHAPTER 6 WORLD CONTRACEPTIVES MARKET, BY EDUCATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Less than high school
6.2.1 Market size and forecast
6.3 High school graduate
6.3.1 Market size and forecast
6.4 College graduate
6.4.1 Market size and forecast
6.5 Other college degrees
6.5.1 Market size and forecast
CHAPTER 7 WORLD CONTRACEPTIVES MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Household
7.2.1 Market size and forecast
7.3 Hospitals
7.3.1 Market size and forecast
7.4 Clinics
7.4.1 Market size and forecast
CHAPTER 8 CONTRACEPTIVES MARKET, BY GEOGRAPHY, 2014-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.3.1 U.S. contraceptives market
8.2.3.2 Canada contraceptives market
8.2.3.3 Mexico contraceptives market
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.3.1 Germany contraceptives market
8.3.3.2 France contraceptives market
8.3.3.3 U.K. contraceptives market
8.3.3.4 Rest of Europe contraceptives market
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.3.1 Japan contraceptives market
8.4.3.2 China contraceptives market
8.4.3.3 Australia contraceptives market
8.4.3.4 India contraceptives market
8.4.3.5 Rest of Asia Pacific contraceptives market
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.3.1 Brazil contraceptives market
8.5.3.2 Turkey contraceptives market
8.5.3.3 Venezuela contraceptives market
8.5.3.4 South Africa contraceptives market
8.5.3.5 Rest of LAMEA contraceptives market
CHAPTER 9 COMPANY PROFILES
9.1 Mylan N.V.
9.1.1 Company overview
9.1.2 Operating business segments
9.1.3 Business performance
9.1.4 Key strategic moves & developments
9.2 Ansell Limited
9.2.1 Company overview
9.2.2 Operating business segments
9.2.3 Business performance
9.2.4 Key strategic moves & developments
9.3 Bayer AG
9.3.1 Company overview
9.3.2 Operating business segments
9.3.3 Business performance
9.3.4 Key strategic moves & developments
9.4 Church & Dwight Co., Inc.
9.4.1 Company overview
9.4.2 Operating business segments
9.4.3 Business performance
9.5 Merck & Co., Inc.
9.5.1 Company overview
9.5.2 Operating business segments
9.5.3 Business performance
9.6 Pfizer Inc.
9.6.1 Company overview
9.6.2 Operating business segments
9.6.3 Business performance
9.6.4 Key strategic moves & developments
9.7 Teva Pharmaceutical Industries Limited
9.7.1 Company overview
9.7.2 Operating business segments
9.7.3 Business performance
9.7.4 Key strategic moves & developments
9.8 The Cooper Companies, Inc.
9.8.1 Company overview
9.8.2 Operating business segments
9.8.3 Business performance
9.8.4 Key strategic moves & developments
9.9 The Female Health Company
9.9.1 Company overview
9.9.2 Operating business segments
9.9.3 Business performance
9.9.4 Key strategic moves & developments
9.10 Mayer Laboratories, Inc.
9.10.1 Company overview
LIST OF TABLES
TABLE 1 WORLD CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 2 WORLD CONTRACEPTIVES MARKET, BY DRUG TYPE, 20142022 ($MILLION)
TABLE 3 WORLD CONTRACEPTIVES MARKET, BY DEVICE TYPE, 20142022 ($MILLION)
TABLE 4 WORLD CONDOM MARKET, BY TYPE, 2014 - 2022 ($MILLION)
TABLE 5 WORLD FEMALE CONDOMS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 6 WORLD MALE CONDOMS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 7 WORLD INTRAUTERINE DEVICES (IUD) MARKET, BY TYPE 2014 2022 ($MILLION)
TABLE 8 WORLD HORMONAL IUDS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 9 WORLD COPPER IUDS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 10 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP, 20142022 ($MILLION)
TABLE 11 WORLD CONTRACEPTIVES MARKET, BY EDUCATION, 20142022 ($MILLION)
TABLE 12 WORLD CONTRACEPTIVES MARKET, BY END USER, 20142022 ($MILLION)
TABLE 13 CONTRACEPTIVES MARKET FOR HOUSEHOLD, BY REGION, 20142022 ($MILLION)
TABLE 14 CONTRACEPTIVES MARKET FOR HOSPITALS, BY REGION, 20142022 ($MILLION)
TABLE 15 CONTRACEPTIVES MARKET FOR CLINICS, BY REGION, 20142022 ($MILLION)
TABLE 16 CONTRACEPTIVES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 NORTH AMERICA: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 18 NORTH AMERICA: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 19 NORTH AMERICA: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 20 NORTH AMERICA: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 22 U.S. CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 23 CANADA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 24 MEXICO CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 25 EUROPE: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 26 EUROPE: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 27 EUROPE: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 28 EUROPE: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 29 EUROPE: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 30 GERMANY CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 31 FRANCE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 32 U.K. CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 33 REST OF EUROPE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 34 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 35 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 36 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 37 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 38 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 39 JAPAN CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 40 CHINA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 41 AUSTRALIA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 42 INDIA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 43 REST OF ASIA PACIFIC CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 44 LAMEA: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 45 LAMEA: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 46 LAMEA: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 47 LAMEA: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 48 LAMEA: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 49 BRAZIL CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 50 TURKEY CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 51 VENEZUELA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 52 SOUTH AFRICA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 53 REST OF LAMEA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 54 ALLERGAN - COMPANY SNAPSHOT
TABLE 55 ALLERGAN - OPERATING SEGMENTS
TABLE 56 ANSELL LIMITED - COMPANY SNAPSHOT
TABLE 57 ANSELL LIMITED - OPERATING SEGMENTS
TABLE 58 BAYER - COMPANY SNAPSHOT
TABLE 59 BAYER - OPERATING SEGMENTS
TABLE 60 CHURCH & DWIGHT - COMPANY SNAPSHOT
TABLE 61 CHURCH & DWIGHT - OPERATING SEGMENTS
TABLE 62 MERCK - COMPANY SNAPSHOT
TABLE 63 MERCK - PRODUCT CATEGORIES
TABLE 64 PFIZER - COMPANY SNAPSHOT
TABLE 65 PFIZER - OPERATING SEGMENTS
TABLE 66 TEVA PHARMACEUTICAL - COMPANY SNAPSHOT
TABLE 67 TEVA PHARMACEUTICAL - OPERATING SEGMENTS
TABLE 68 COOPER - COMPANY SNAPSHOT
TABLE 69 COOPER: OPERATING SEGMENTS
TABLE 70 FHC - COMPANY SNAPSHOT
TABLE 71 MAYER - COMPANY SNAPSHOT
TABLE 1 WORLD CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 2 WORLD CONTRACEPTIVES MARKET, BY DRUG TYPE, 20142022 ($MILLION)
TABLE 3 WORLD CONTRACEPTIVES MARKET, BY DEVICE TYPE, 20142022 ($MILLION)
TABLE 4 WORLD CONDOM MARKET, BY TYPE, 2014 - 2022 ($MILLION)
TABLE 5 WORLD FEMALE CONDOMS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 6 WORLD MALE CONDOMS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 7 WORLD INTRAUTERINE DEVICES (IUD) MARKET, BY TYPE 2014 2022 ($MILLION)
TABLE 8 WORLD HORMONAL IUDS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 9 WORLD COPPER IUDS MARKET, BY REGION, 2014 - 2022 ($MILLION)
TABLE 10 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP, 20142022 ($MILLION)
TABLE 11 WORLD CONTRACEPTIVES MARKET, BY EDUCATION, 20142022 ($MILLION)
TABLE 12 WORLD CONTRACEPTIVES MARKET, BY END USER, 20142022 ($MILLION)
TABLE 13 CONTRACEPTIVES MARKET FOR HOUSEHOLD, BY REGION, 20142022 ($MILLION)
TABLE 14 CONTRACEPTIVES MARKET FOR HOSPITALS, BY REGION, 20142022 ($MILLION)
TABLE 15 CONTRACEPTIVES MARKET FOR CLINICS, BY REGION, 20142022 ($MILLION)
TABLE 16 CONTRACEPTIVES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 NORTH AMERICA: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 18 NORTH AMERICA: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 19 NORTH AMERICA: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 20 NORTH AMERICA: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 22 U.S. CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 23 CANADA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 24 MEXICO CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 25 EUROPE: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 26 EUROPE: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 27 EUROPE: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 28 EUROPE: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 29 EUROPE: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 30 GERMANY CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 31 FRANCE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 32 U.K. CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 33 REST OF EUROPE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 34 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 35 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 36 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 37 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 38 ASIA PACIFIC: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 39 JAPAN CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 40 CHINA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 41 AUSTRALIA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 42 INDIA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 43 REST OF ASIA PACIFIC CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 44 LAMEA: CONTRACEPTIVES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 45 LAMEA: CONTRACEPTIVES MARKET, BY DRUG TYPE, 2014-2022 ($MILLION)
TABLE 46 LAMEA: CONTRACEPTIVES MARKET, BY DEVICES TYPE, 2014-2022 ($MILLION)
TABLE 47 LAMEA: CONTRACEPTIVES MARKET, BY AGE GROUP, 2014-2022 ($MILLION)
TABLE 48 LAMEA: CONTRACEPTIVES MARKET, BY EDUCATION, 2014-2022 ($MILLION)
TABLE 49 BRAZIL CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 50 TURKEY CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 51 VENEZUELA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 52 SOUTH AFRICA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 53 REST OF LAMEA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)
TABLE 54 ALLERGAN - COMPANY SNAPSHOT
TABLE 55 ALLERGAN - OPERATING SEGMENTS
TABLE 56 ANSELL LIMITED - COMPANY SNAPSHOT
TABLE 57 ANSELL LIMITED - OPERATING SEGMENTS
TABLE 58 BAYER - COMPANY SNAPSHOT
TABLE 59 BAYER - OPERATING SEGMENTS
TABLE 60 CHURCH & DWIGHT - COMPANY SNAPSHOT
TABLE 61 CHURCH & DWIGHT - OPERATING SEGMENTS
TABLE 62 MERCK - COMPANY SNAPSHOT
TABLE 63 MERCK - PRODUCT CATEGORIES
TABLE 64 PFIZER - COMPANY SNAPSHOT
TABLE 65 PFIZER - OPERATING SEGMENTS
TABLE 66 TEVA PHARMACEUTICAL - COMPANY SNAPSHOT
TABLE 67 TEVA PHARMACEUTICAL - OPERATING SEGMENTS
TABLE 68 COOPER - COMPANY SNAPSHOT
TABLE 69 COOPER: OPERATING SEGMENTS
TABLE 70 FHC - COMPANY SNAPSHOT
TABLE 71 MAYER - COMPANY SNAPSHOT
LIST OF FIGURES
FIG. 1 MARKET SEGMENTATION FOR CONTRACEPTIVES MARKET
FIG. 2 TOP INVESTMENT POCKETS
FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20142016)
FIG. 4 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 5 PORTERS FIVE FORCES ANALYSIS
FIG. 6 PRIVATELY INSURED WOMEN PERCENTAGE WHO PAID $0 FOR THE CONTRACEPTIVE METHOD
FIG. 7 TOP IMPACTING FACTORS
FIG. 8 PERCENTAGE OF PREGNANCY BY INTENTION
FIG. 9 WORLD CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2015 (%)
FIG. 10 WORLD ORAL CONTRACEPTIVES OR PILLS MARKET, 2014 - 2022 ($MILLION)
FIG. 11 WORLD CONTRACEPTIVES INJECTABLES MARKET, 2014 - 2022 ($MILLION)
FIG. 12 WORLD TOPICAL CONTRACEPTIVES MARKET, 2014 - 2022 ($MILLION)
FIG. 13 WORLD CONTRACEPTIVE DIAPHRAGM MARKET, 2014 - 2022 ($MILLION)
FIG. 14 WORLD CONTRACEPTIVE SPONGE MARKET, 2014 - 2022 ($MILLION)
FIG. 15 WORLD CONTRACEPTIVE PATCH MARKET, 2014 - 2022 ($MILLION)
FIG. 16 WORLD SUB-DERMAL CONTRACEPTIVE IMPLANTS MARKET, 2014 - 2022 ($MILLION)
FIG. 17 WORLD VAGINAL RINGS MARKET, 2014 - 2022 ($MILLION)
FIG. 18 WORLD OTHER CONTRACEPTIVE DEVICES MARKET, 2014 - 2022 ($MILLION)
FIG. 19 WORLD CONTRACEPTIVES MARKET FOR 15-24 YEARS, 2014 - 2022 ($MILLION)
FIG. 20 WORLD CONTRACEPTIVES MARKET FOR 25-34 YEARS, 2014 - 2022 ($MILLION)
FIG. 21 WORLD CONTRACEPTIVES MARKET FOR 35-44 YEARS, 2014 - 2022 ($MILLION)
FIG. 22 WORLD CONTRACEPTIVES MARKET FOR ABOVE 44 YEARS, 2014 - 2022 ($MILLION)
FIG. 23 WORLD CONTRACEPTIVES MARKET FOR LESS THAN HIGH SCHOOL, 2014 - 2022 ($MILLION)
FIG. 24 WORLD CONTRACEPTIVES MARKET FOR HIGH SCHOOL GRADUATE, 2014 - 2022 ($MILLION)
FIG. 25 WORLD CONTRACEPTIVES MARKET FOR COLLEGE GRADUATE, 2014 - 2022 ($MILLION)
FIG. 26 WORLD CONTRACEPTIVES MARKET FOR OTHER COLLEGE DEGREES, 2014 - 2022 ($MILLION)
FIG. 27 WORLD CONTRACEPTIVES MARKET, BY END USER, 2015 (%)
FIG. 28 CONTRACEPTIVES MARKET FOR HOUSEHOLD, BY REGION, 2014 - 2022 (%)
FIG. 29 CONTRACEPTIVES MARKET FOR HOSPITAL, BY REGION, 2014 - 2022 (%)
FIG. 30 CONTRACEPTIVES MARKET FOR CLINICS, BY REGION, 2014 - 2022 (%)
FIG. 31 MORE EFFECTIVE CONTRACEPTIVES USE, BY COUNTRY
FIG. 32 WORLD CONTRACEPTIVES MARKET, BY REGION, 2015 (%)
FIG. 33 NORTH AMERICA CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 34 U.K.: CONTRACEPTION USE BY WOMEN, BY AGE, 20082009
FIG. 35 EUROPE CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 36 ASIA PACIFIC CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 37 LAMEA CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 38 ALLERGAN: NET SALES, 20132015 ($MILLION)
FIG. 39 ALLERGAN: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 40 ALLERGAN: STRATEGY SHARE, 20142016 (%)
FIG. 41 ANSELL LIMITED: NET SALES, 20132015 ($MILLION)
FIG. 42 ANSELL LIMITED: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 43 ANSELL LIMITED: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 44 ANSELL LIMITED: STRATEGY SHARE, 20152016 (%)
FIG. 45 BAYER: NET SALES, 20132015 ($MILLION)
FIG. 46 BAYER: NET SALES, BY SEGMENTS, 2015 (%)
FIG. 47 BAYER: NET SALES, BY GEOGRAPHY, 2015(%)
FIG. 48 CHURCH & DWIGHT: NET SALES, 20132015 ($MILLION)
FIG. 49 CHURCH & DWIGHT: NET SALES, BY SEGMENT, 2015, (%)
FIG. 50 MERCK: NET SALES, 20132015 ($MILLION)
FIG. 51 MERCK: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 52 MERCK: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 53 PFIZER: NET SALES, 20132015 ($MILLION)
FIG. 54 PFIZER: NET SALES, BY SEGMENT, 2015 (%)
FIG. 55 PFIZER: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 56 PFIZER: STRATEGY SHARE, (%)
FIG. 57 TEVA PHARMACEUTICAL: NET SALES, 20132015 ($MILLION)
FIG. 58 TEVA PHARMACEUTICAL: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 59 TEVA PHARMACEUTICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 60 COOPER: NET SALES, 20132015 ($MILLION)
FIG. 61 COOPER: NET SALES, BY BUSINESS SEGMENT, 2015 ($MILLION)
FIG. 62 COOPER: NET SALES, BY GEOGRAPHY, 2015, (%)
FIG. 63 FHC: NET SALES, 20132015 ($MILLION)
FIG. 64 FHC: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIG. 65 FHC: STRATEGY SHARE (%), 20142016
FIG. 1 MARKET SEGMENTATION FOR CONTRACEPTIVES MARKET
FIG. 2 TOP INVESTMENT POCKETS
FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20142016)
FIG. 4 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 5 PORTERS FIVE FORCES ANALYSIS
FIG. 6 PRIVATELY INSURED WOMEN PERCENTAGE WHO PAID $0 FOR THE CONTRACEPTIVE METHOD
FIG. 7 TOP IMPACTING FACTORS
FIG. 8 PERCENTAGE OF PREGNANCY BY INTENTION
FIG. 9 WORLD CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2015 (%)
FIG. 10 WORLD ORAL CONTRACEPTIVES OR PILLS MARKET, 2014 - 2022 ($MILLION)
FIG. 11 WORLD CONTRACEPTIVES INJECTABLES MARKET, 2014 - 2022 ($MILLION)
FIG. 12 WORLD TOPICAL CONTRACEPTIVES MARKET, 2014 - 2022 ($MILLION)
FIG. 13 WORLD CONTRACEPTIVE DIAPHRAGM MARKET, 2014 - 2022 ($MILLION)
FIG. 14 WORLD CONTRACEPTIVE SPONGE MARKET, 2014 - 2022 ($MILLION)
FIG. 15 WORLD CONTRACEPTIVE PATCH MARKET, 2014 - 2022 ($MILLION)
FIG. 16 WORLD SUB-DERMAL CONTRACEPTIVE IMPLANTS MARKET, 2014 - 2022 ($MILLION)
FIG. 17 WORLD VAGINAL RINGS MARKET, 2014 - 2022 ($MILLION)
FIG. 18 WORLD OTHER CONTRACEPTIVE DEVICES MARKET, 2014 - 2022 ($MILLION)
FIG. 19 WORLD CONTRACEPTIVES MARKET FOR 15-24 YEARS, 2014 - 2022 ($MILLION)
FIG. 20 WORLD CONTRACEPTIVES MARKET FOR 25-34 YEARS, 2014 - 2022 ($MILLION)
FIG. 21 WORLD CONTRACEPTIVES MARKET FOR 35-44 YEARS, 2014 - 2022 ($MILLION)
FIG. 22 WORLD CONTRACEPTIVES MARKET FOR ABOVE 44 YEARS, 2014 - 2022 ($MILLION)
FIG. 23 WORLD CONTRACEPTIVES MARKET FOR LESS THAN HIGH SCHOOL, 2014 - 2022 ($MILLION)
FIG. 24 WORLD CONTRACEPTIVES MARKET FOR HIGH SCHOOL GRADUATE, 2014 - 2022 ($MILLION)
FIG. 25 WORLD CONTRACEPTIVES MARKET FOR COLLEGE GRADUATE, 2014 - 2022 ($MILLION)
FIG. 26 WORLD CONTRACEPTIVES MARKET FOR OTHER COLLEGE DEGREES, 2014 - 2022 ($MILLION)
FIG. 27 WORLD CONTRACEPTIVES MARKET, BY END USER, 2015 (%)
FIG. 28 CONTRACEPTIVES MARKET FOR HOUSEHOLD, BY REGION, 2014 - 2022 (%)
FIG. 29 CONTRACEPTIVES MARKET FOR HOSPITAL, BY REGION, 2014 - 2022 (%)
FIG. 30 CONTRACEPTIVES MARKET FOR CLINICS, BY REGION, 2014 - 2022 (%)
FIG. 31 MORE EFFECTIVE CONTRACEPTIVES USE, BY COUNTRY
FIG. 32 WORLD CONTRACEPTIVES MARKET, BY REGION, 2015 (%)
FIG. 33 NORTH AMERICA CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 34 U.K.: CONTRACEPTION USE BY WOMEN, BY AGE, 20082009
FIG. 35 EUROPE CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 36 ASIA PACIFIC CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 37 LAMEA CONTRACEPTIVES MARKET, BY COUNTRY, 2014 - 2022 (%)
FIG. 38 ALLERGAN: NET SALES, 20132015 ($MILLION)
FIG. 39 ALLERGAN: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 40 ALLERGAN: STRATEGY SHARE, 20142016 (%)
FIG. 41 ANSELL LIMITED: NET SALES, 20132015 ($MILLION)
FIG. 42 ANSELL LIMITED: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 43 ANSELL LIMITED: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 44 ANSELL LIMITED: STRATEGY SHARE, 20152016 (%)
FIG. 45 BAYER: NET SALES, 20132015 ($MILLION)
FIG. 46 BAYER: NET SALES, BY SEGMENTS, 2015 (%)
FIG. 47 BAYER: NET SALES, BY GEOGRAPHY, 2015(%)
FIG. 48 CHURCH & DWIGHT: NET SALES, 20132015 ($MILLION)
FIG. 49 CHURCH & DWIGHT: NET SALES, BY SEGMENT, 2015, (%)
FIG. 50 MERCK: NET SALES, 20132015 ($MILLION)
FIG. 51 MERCK: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 52 MERCK: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 53 PFIZER: NET SALES, 20132015 ($MILLION)
FIG. 54 PFIZER: NET SALES, BY SEGMENT, 2015 (%)
FIG. 55 PFIZER: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 56 PFIZER: STRATEGY SHARE, (%)
FIG. 57 TEVA PHARMACEUTICAL: NET SALES, 20132015 ($MILLION)
FIG. 58 TEVA PHARMACEUTICAL: NET SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 59 TEVA PHARMACEUTICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 60 COOPER: NET SALES, 20132015 ($MILLION)
FIG. 61 COOPER: NET SALES, BY BUSINESS SEGMENT, 2015 ($MILLION)
FIG. 62 COOPER: NET SALES, BY GEOGRAPHY, 2015, (%)
FIG. 63 FHC: NET SALES, 20132015 ($MILLION)
FIG. 64 FHC: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIG. 65 FHC: STRATEGY SHARE (%), 20142016
